Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prediction and decision making using Bayesian hierarchical models

D K Stangl1

  • 1Institute of Statistics and Decision Sciences, Terry Sanford Institute of Public Policy, Duke University, Durham, NC 27708-0251, USA.

Statistics in Medicine
|October 30, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use, persistence, and intensity: patterns of care for children's mental health across one year.

Community mental health journal·1999
Same author

Assessing placebo response using Bayesian hierarchical survival models.

Lifetime data analysis·1998
Same author

The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders.

Archives of general psychiatry·1996
Same author

The Great Smoky Mountains Study of Youth. Functional impairment and serious emotional disturbance.

Archives of general psychiatry·1996
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
See all related articles

This study introduces Bayesian hierarchical models for analyzing complex clinical trial data with continuous, non-normally distributed outcomes and censoring. The method provides robust survival estimates for subgroups and assesses heterogeneity, enhancing clinical trial analysis.

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Psychiatric Research

Background:

  • Multi-centre clinical trial data often involves continuous, non-normally distributed outcomes with censoring.
  • Subgroup analyses are crucial for understanding treatment effects in specific patient populations.
  • Assessing heterogeneity between subgroups is essential for interpreting trial results.

Purpose of the Study:

  • To develop and illustrate Bayesian hierarchical models for analyzing complex multi-centre clinical trial data.
  • To provide survival estimates for specific subgroups and the overall population.
  • To quantify the degree of heterogeneity between subgroups.

Main Methods:

  • Application of Bayesian hierarchical models to continuous, non-normally distributed, and censored clinical trial data.

Related Experiment Videos

  • Utilizing a changepoint model to account for drug washout periods.
  • Comparison of different model choices and prior parameter values.

    • Main Results:

    • Demonstration of the proposed methodology using data from the Collaborative Study of Long-Term Maintenance Drug Therapy in Recurrent Affective Illness.
    • Evaluation of model sensitivity to choice of priors within a decision theory framework.
    • Quantification of survival estimates and heterogeneity across subgroups.

    Conclusions:

    • Bayesian hierarchical models offer a flexible and robust approach for analyzing complex clinical trial data.
    • The methodology effectively handles non-normal outcomes, censoring, and subgroup heterogeneity.
    • The study provides valuable insights into treatment effects and patient variability in recurrent affective illness.